Ultragenyx Pharmaceutical Inc. Earnings logo

RARE

Ultragenyx Pharmaceutical Inc. Earnings

$41.4

Earnings Summary

Revenue
$139.29Mn
Net Profits
$-151.08Mn
Net Profit Margins
-108.46%
Highlights
Revenue:

Ultragenyx Pharmaceutical Inc.’s revenue jumped 27.99% since last year same period to $139.29Mn in the Q1 2025. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated -15.52% fall in its revenue since last 3-months.

Net Profits:

Ultragenyx Pharmaceutical Inc.’s net profit jumped 11.49% since last year same period to $-151.08Mn in the Q1 2025. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated -13.27% fall in its net profits since last 3-months.

Net Profit Margins:

Ultragenyx Pharmaceutical Inc.’s net profit margin jumped 30.84% since last year same period to -108.46% in the Q1 2025. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated -34.07% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ultragenyx Pharmaceutical Inc. post its latest quarter earnings
EPS Estimate Current Quarter
-1.29
EPS Estimate Current Year
-1.29
Highlights
EPS Estimate Current Quarter:

Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.29 - a -0.78% fall from last quarter’s estimates.

EPS Estimate Current Year:

Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at -1.29.

Key Ratios

Key ratios of the Ultragenyx Pharmaceutical Inc. post its Q3 2025 earnings
Earning Per Share (EPS)
0
Highlights
Earning Per Share (EPS):

Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ultragenyx Pharmaceutical Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-11-04
-1.29
0
100%
2025-05-07
-1.75
-1.57
10.29%
2025-07-31
-1.28
0
100%